LFCR
Lifecore Biomedical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.40
+1.15%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-20.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 8, 2026 | Kiper Christopher S · director, 10 percent owner: | A-Award | 25,907 | $0.00 |
| Jun 5, 2026 | Antunes Humberto Calheiros · director | A-Award | 25,907 | $0.00 |
| Jun 5, 2026 | Johnson Paul Harold · director | A-Award | 25,907 | $0.00 |
| Jun 5, 2026 | HOUDE LOVAS KATRINA · director | A-Award | 25,907 | $0.00 |
| Jun 5, 2026 | Korenberg Matthew E · director | A-Award | 25,907 | $0.00 |
| Jun 5, 2026 | OBUS NELSON · director | A-Award | 25,907 | $0.00 |
| Jun 5, 2026 | Aryeh Jason · director | A-Award | 25,907 | $0.00 |
| Jun 5, 2026 | Schechter Joshua · director | A-Award | 25,907 | $0.00 |
| May 21, 2026 | Josephs Paul · director, officer: Chief Executive Officer | F-InKind | 40,413 | $4.57 |
| Apr 16, 2026 | Salus Thomas D. · officer: Chief Legal & Administration | F-InKind | 24,645 | $5.20 |
| Mar 2, 2026 | Salus Thomas D. · officer: Chief Legal & Administration | A-Award | 30,000 | $0.00 |
| Sep 4, 2025 | Lake Ryan David · officer: Chief Financial Officer | F-InKind | 22,932 | $7.71 |
| Jul 17, 2025 | HOUDE LOVAS KATRINA · director | A-Award | 19,506 | $0.00 |
| Jul 17, 2025 | Johnson Paul Harold · director | A-Award | 19,506 | $0.00 |
| Jul 17, 2025 | Aryeh Jason · director | A-Award | 19,506 | $0.00 |
| Jul 17, 2025 | Korenberg Matthew E · director | A-Award | 19,506 | $0.00 |
| Jul 17, 2025 | Antunes Humberto Calheiros · director | A-Award | 19,506 | $0.00 |
| Jul 17, 2025 | Schechter Joshua · director | A-Award | 19,506 | $0.00 |
| Jul 17, 2025 | OBUS NELSON · director | A-Award | 19,506 | $0.00 |
| Jul 17, 2025 | Kiper Christopher S · director, 10 percent owner: | A-Award | 19,506 | $0.00 |
| Jul 10, 2025 | Lake Ryan David · officer: Chief Financial Officer | F-InKind | 32,806 | $8.19 |
| Jul 10, 2025 | Lake Ryan David · officer: Chief Financial Officer | M-Exempt | 75,000 | $0.00 |
| Jul 10, 2025 | Salus Thomas D. · officer: Chief Legal & Administration | F-InKind | 11,022 | $8.19 |
| Jul 10, 2025 | Salus Thomas D. · officer: Chief Legal & Administration | M-Exempt | 37,000 | $0.00 |
| Jul 10, 2025 | Josephs Paul · director, officer: Chief Executive Officer | F-InKind | 54,857 | $8.19 |
| Jul 10, 2025 | Josephs Paul · director, officer: Chief Executive Officer | M-Exempt | 150,000 | $0.00 |
| May 28, 2025 | English Aron R. · 10 percent owner | Sale | 1,139,504 | $6.50 |
| May 28, 2025 | English Aron R. · 10 percent owner | Sale | 150,419 | $7.12 |
| May 28, 2025 | English Aron R. · 10 percent owner | Sale | 96,137 | $6.75 |
| May 22, 2025 | Josephs Paul · director, officer: Chief Executive Officer | F-InKind | 21,532 | $6.63 |
Institutional positioning
13F filings over the trailing two quarters
New 36Increased 65Reduced 60Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| WYNNEFIELD CAPITAL INC | Unchanged | 4,703,216 | May 15, 2026 |
| WYNNEFIELD CAPITAL INC | Unchanged | 4,703,216 | Aug 14, 2026 |
| Legion Partners Asset Management, LLC | Unchanged | 4,461,823 | Aug 14, 2026 |
| LEGION PARTNERS ASSET MANAGEMENT, LLC | Unchanged | 4,461,823 | May 15, 2026 |
| GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. | Reduced | 3,537,573 | May 15, 2026 |
| Greenhaven Road Investment Management, L.P. | Reduced | 3,190,769 | Aug 14, 2026 |
| 325 CAPITAL LLC | Increased | 2,895,881 | Aug 14, 2026 |
| 325 CAPITAL LLC | Unchanged | 2,162,466 | May 15, 2026 |
| BlackRock, Inc. | Increased | 2,013,093 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 1,877,305 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,290,136 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 1,288,621 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 855,500 | Aug 12, 2026 |
| GRIZZLYROCK CAPITAL, LLC | Increased | 827,488 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 815,107 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 8, 2026